Sign in
WithdrawnNo phase

Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers

Key facts

Who runs it
GCS Ramsay Santé pour l'Enseignement et la Recherche
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
1 Jan 2024
Ended
30 Jun 2024
Type of study
Observational, 2 groups
Treatments tested
  • PCR - Immunohistochemistry - Immunolabelling
Record updated
20 August 2026
Why it stopped
Feasibility issue

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patient with oropharyngeal squamous cell carcinoma or the oral cavity histologically proven
  • Primary tumor for which a biopsy or excision is required available and sufficient to carry out molecular analysis

Who cannot take part

  • Patient with Head and Neck cancer other than oropharyngeal or oral cavity squamous cells carcinomas

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Squamous cell cancers of the head and neck are classically correlated to excessive consumption of alcohol and tobacco and have a rather poor prognosis. However, the incidence of Head and Neck cancers in patients without alcohol-smoking risk factor has continued to increase in recent years, in relation to more and more frequent HPV contamination.

Read full original descriptionShow less

Some studies show a difference in the expression of certain genes within the two groups of tumors (HPV+ and HPV-) including some that confer sensitivity to certain chemotherapies and others to radiotherapy. However, patients with HPV+ Head and Neck cancers are treated according to the same referential as HPV- Head and Neck cancers. There is therefore a real need for studies identifying predictive markers in order to be able to offer patients a more effective suitable and less invasive treatment.

The 2 groups in the trial

  • HPV + Group

    Patients with positive HPV diagnosis

    Treatment: PCR - Immunohistochemistry - Immunolabelling

  • HPV - Group

    Patients with negative HPV diagnosis

    Treatment: PCR - Immunohistochemistry - Immunolabelling

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Genomic Alterations and Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
Record updated
20 August 2026